Browsing Tag
Arcellx Inc.
3 posts
Gilead Sciences to double down on CAR T with $7.8bn Arcellx acquisition
Find out how Gilead Sciences’ $7.8 billion Arcellx acquisition reshapes the future of anito-cel and the competitive landscape in multiple myeloma.
Wall Street top gainers: WeRide, XPeng, Dycom, GDS lead the charge as markets slide
Find out which stocks defied the selloff on May 21, 2025. WeRide, XPeng, and Dycom surged amid market turbulence. Full gainer list and investor analysis.
Why New Fortress Energy, Rocket Companies, and Avidity Biosciences are surging despite economic warnings
Find out which US stocks surged on April 2, 2025, and what rising tariffs and policy shifts mean for investors navigating today’s volatile market.